2012, Percutaneous Coronary Intervention (PCI) vs CABG in Patients with Diabetes and multivessel CAD
2006, Clopidogrel and aspirin versus aspirin alone for prevention of atherothrombosis, NEJM
2013, Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events, NEJM
2008, Extended-release metoprolol succinate in patients undergoing non-cardiac surgery, The Lancet
2007, PCI + medical therapy vs medical therapy only in stable coronary artery disease, NEJM Courage Trial Summary COURAGE was a randomized, open label, multicenter (50 centers in US & Canada), co-industry sponsored, clinical trial which tested the hypothesis that PCI with optimal medical therapy (OMT) is superior to OMT alone in reducing primary outcome..